Skip to content
Screener

Baxter International BAX Pharmaceuticals — Goodwill

Other segment segments

Healthcare Systems & Technologies
$3.08B-13.4%
Medical Products & Therapies
$1.25B+2.0%

Similar metrics at other companies

Bausch + Lomb logo
BLCOPharmaceuticals — Goodwill
$720M-3.7%
Opko Health logo
OPKPharmaceutical — Goodwill
$318.07M-0.8%
McKesson logo
MCKNorth American Pharmaceutical — Goodwill
$2.76B—
AMP
AMPHFinished Pharmaceutical Products — Goodwill
$3.31M-2.5%
Cardinal Health logo
CAHPharmaceutical and Specialty Solutions — Goodwill
$9.67B+25.0%
Constellation Brands logo
STZConstellationwinesandspirits — Goodwill
$5.23B+2.1%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.13B+22.3%
Enterprise value$12.33B+22.1%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%—
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0×0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The source filing: Baxter International’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028962
(in millions)Medical Products & TherapiesHealthcare Systems & TechnologiesPharmaceuticalsTotal
Balance as of December 31, 2025$1,265$3,087$577$4,929
Currency translation(17)(5)(8)(30)
Balance as of March 31, 2026$1,248$3,082$569$4,899

Item 1. Financial Statements (unaudited)

FAQ

What is Baxter International's pharmaceuticals — goodwill?
Baxter International (BAX) reported pharmaceuticals — goodwill of $569M in Q1 2026.
How has Baxter International's pharmaceuticals — goodwill changed year-over-year?
Baxter International's pharmaceuticals — goodwill increased by 2.2% year-over-year, from $557M to $569M.
What does pharmaceuticals — goodwill mean?
Represents the intangible asset value recorded when the Pharmaceuticals segment was acquired, reflecting the premium paid over the fair value of net identifiable assets. It serves as a long-term asset on the balance sheet that is subject to periodic impairment testing to ensure its carrying value does not exceed its recoverable amount.

Ask your AI about Baxter International's pharmaceuticals — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude